Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 770 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cellectricon introduces Cellaxess discovery platform

Developed in collaboration with pharma and biotechnology companies, the Cellaxess platform enables scalable field stimulation, compound delivery and transfection for genomic screening of primary cells, neurones and stem

C3 Jian soon to initiate Phase I trial of C16G2

C16G2 is a synthetic peptide derived from C3 Jian’s proprietary Specifically Targeted Antimicrobial Peptides (STAMPS) technology which has demonstrated activity selectively targeting Streptococcus mutans, a cavity-causing organism. The

FDA approves Aurobindo Pharma generic HIV drug

The FDA approved Nevirapine tablets of 200mg strength and Nevirapine oral suspension of 50mg/5ml strength, the company said. The drug is used as a part of antiretroviral combination

APP buys three injectable products from Nexus

As per the agreement, APP acquires complete ownership and becomes the abbreviated new drug application holder of the products. APP president and chief executive officer John Ducker said,